(Circulation. 1997;96:56-60.)
© 1997 American Heart Association, Inc.
Articles |
D Allele of the Angiotensin I–Converting Enzyme Is a Major Risk Factor for Restenosis After Coronary Stenting
From INSERM CJF 95-05, Institut Pasteur de Lille (C.A., F.R., N.H., P.A.); University and CHRU de Lille (C.B., J.-C.B., J.-M.L., M.H., F.R., E.P.M., P.A., M.E.B.); University and CHRU de Caen (G.G.); and University and CHRU de Nancy (N.D.), France.
Correspondence to M.E. Bertrand, MD, Service de Cardiologie B, Hôpital Cardiologique, Blvd du Professeur J Leclercq, 59037 Lille Cedex, France.
Background Although intracoronary stent implantation significantly reduces restenosis compared with balloon angioplasty, a minority of patients still develop restenosis predominantly due to neointimal hyperplasia. Experimental studies suggest that the renin-angiotensin system is involved in neointimal hyperplasia after arterial injury. In humans, the plasma and cellular levels of ACE are associated with an I/D genetic polymorphism in the ACE gene, DD patients having higher levels.
Methods and Results We investigated a possible relation between the ACE I/D polymorphism and restenosis in 146 patients who underwent successful implantation of a Palmaz-Schatz stent and had 6-month follow-up angiography. The minimal lumen diameter (MLD) before and after the procedure did not differ significantly among the three groups of genotypes (DD, ID, and II). At follow-up, MLD had a significant inverse relationship to the number of D alleles present (DD, 1.65±0.71 mm; ID, 1.84±0.60 mm; II, 2.05±0.61 mm; P<.007). Late luminal loss during the follow-up period was significantly related to the number of D alleles (DD, 0.89±0.61 mm; ID, 0.60±0.52 mm; II, 0.40±0.53 mm; P<.0001). The relative risk of restenosis (defined as a >50% diameter stenosis at follow-up) approximated by the adjusted odds ratio was 2.00 per number of D alleles (95% confidence interval, 1.03 to 3.88, P<.04).
Conclusions The ACE I/D polymorphism influences the level of late luminal loss after coronary stent implantation. These results suggest that the renin-angiotensin system may be implicated in the pathogenesis of restenosis after coronary stenting.
Key Words: angiotensin • coronary disease • genetics
This article has been cited by other articles:
 |
|
 |
|
  T. Altin, B. Berkalp, C. Ozdol, O. Akyurek, T. Sayin, C. Kervancioglu, D. Oral, and C. Erol Angiographic Restenosis in Ephesos Coronary Stents: Experience From a Large Medical Center in Ankara, Turkey Angiology, March 1, 2008; 59(1): 47 - 51. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Dumont, M. Zureik, C. Bauters, M.-C. Grupposo, D. Cottel, M. Montaye, M. Hamon, P. Ducimetiere, P. Amouyel, and T. Brousseau Association of OAZ1 Gene Polymorphisms With Subclinical and Clinical Vascular Events Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2120 - 2126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Rivera, M. P. Ocaranza, S. Lavandero, and J. E. Jalil Rho Kinase Activation and Gene Expression Related to Vascular Remodeling in Normotensive Rats With High Angiotensin I Converting Enzyme Levels Hypertension, October 1, 2007; 50(4): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Yates and M. Stafford-Smith The genetic determinants of renal impairment following cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 314 - 326. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Jalil, A. Perez, M. P. Ocaranza, J. Bargetto, A. Galaz, and S. Lavandero Increased Aortic NADPH Oxidase Activity in Rats With Genetically High Angiotensin-Converting Enzyme Levels Hypertension, December 1, 2005; 46(6): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Arnett, B. R. Davis, C. E. Ford, E. Boerwinkle, C. Leiendecker-Foster, M. B. Miller, H. Black, and J. H. Eckfeldt Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment: The Genetics of Hypertension-Associated Treatment (GenHAT) Study Circulation, June 28, 2005; 111(25): 3374 - 3383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J Wagenaar, A. J van Boven, A. C van der Wal, G. Amoroso, R. A Tio, C. M van der Loos, A. E Becker, and W. H van Gilst Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries Cardiovasc Res, October 1, 2003; 59(4): 980 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koch, J. Mehilli, N. von Beckerath, C. Bottiger, A. Schomig, and A. Kastrati Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1957 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schieffer and H. Drexler The race for ACE: A simple answer to the controversial puzzle of angiotensin-converting enzyme (ACE) polymorphisms J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1962 - 1963. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Jacoby and D. J. Rader Renin-Angiotensin System and Atherothrombotic Disease: From Genes to Treatment Arch Intern Med, May 26, 2003; 163(10): 1155 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hamon, S Fradin, A Denizet, E Filippi-Codaccioni, G Grollier, and R Morello Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention Heart, March 1, 2003; 89(3): 321 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.H. Gomma, M.A. Elrayess, C.J. Knight, E. Hawe, K.M. Fox, and S.E. Humphries The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis Eur. Heart J., December 2, 2002; 23(24): 1955 - 1962. [Abstract] [PDF]
|
|
|
|
 |
|
 F. Bonnici, B. Keavney, R. Collins, and J. Danesh Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies BMJ, September 7, 2002; 325(7363): 517 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Le Blanche, M. Bonneau, M. Wassef, M.-T. Farres, L. Gabez, B. Aubert, M. Duriez, B. I. Levy, J.-M. Bigot, and F. Boudghene Histomorphometric Evaluation of 198Au Endovascular Brachytherapy in a Renal Artery Restenosis Model in Rabbits Am. J. Roentgenol., September 1, 2002; 179(3): 611 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Humphries, C. Bauters, A. Meirhaeghe, L. Luong, M. Bertrand, and P. Amouyel The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis Eur. Heart J., May 1, 2002; 23(9): 721 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF]
|
|
|
|
|
|
E. Jorgensen, H. Kelbaek, S. Helqvist, G. V. H. Jensen, K. Saunamaki, J. Kastrup, O. Havndrup, H. Bundgaard, J. Kyst Madsen, M. Christiansen, et al. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1434 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Ahmed, G. S. Mintz, R. Waksman, R. Mehran, B. Leiboff, A. D. Pichard, L. F. Satler, K. M. Kent, and N. J. Weissman Serial Intravascular Ultrasound Assessment of the Efficacy of Intracoronary {gamma}-Radiation Therapy for Preventing Recurrence in Very Long, Diffuse, In-Stent Restenosis Lesions Circulation, August 21, 2001; 104(8): 856 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Y. L. Zee, A. Fernandez-Ortiz, C. Macaya, E. Pintor, K. Lindpaintner, and A. Fernandez-Cruz ACE D/I Polymorphism and Incidence of Post-PTCA Restenosis : A Prospective, Angiography-Based Evaluation Hypertension, March 1, 2001; 37(3): 851 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Crisan and J. Carr Angiotensin I-Converting Enzyme: Genotype and Disease Associations J. Mol. Diagn., August 1, 2000; 2(3): 105 - 115. [Full Text]
|
|
|
|
|
|
W. Koch, A. Kastrati, J. Mehilli, C. Bottiger, N. von Beckerath, and A. Schomig Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene Is Not Associated With Restenosis After Coronary Stent Placement Circulation, July 11, 2000; 102(2): 197 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goldschmidt-Clermont, G. E. Cooke, G. M. Eaton, and P. F. Binkley PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications J. Am. Coll. Cardiol., July 1, 2000; 36(1): 90 - 93. [Full Text] [PDF]
|
|
|
|
|
|
B. Agerholm-Larsen, B. G. Nordestgaard, and A. Tybjarg-Hansen ACE Gene Polymorphism in Cardiovascular Disease : Meta-Analyses of Small and Large Studies in Whites Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mehran, G. Dangas, A. S. Abizaid, G. S. Mintz, A. J. Lansky, L. F. Satler, A. D. Pichard, K. M. Kent, G. W. Stone, and M. B. Leon Angiographic Patterns of In-Stent Restenosis : Classification and Implications for Long-Term Outcome Circulation, November 2, 1999; 100(18): 1872 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Okamura, M. Ohishi, H. Rakugi, T. Katsuya, Y. Yanagitani, S. Takiuchi, Y. Taniyama, K. Moriguchi, H. Ito, Y. Higashino, et al. Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty Angiology, October 1, 1999; 50(10): 811 - 822. [Abstract] [PDF]
|
|
|
|
|
|
J W. JUKEMA Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease Heart, August 1, 1999; 82(2): 126 - 127. [Full Text] [PDF]
|
|
|
|
|
|
M. E. Bertrand and C. Bauters Cytomegalovirus Infection and Coronary Restenosis Circulation, March 16, 1999; 99(10): 1278 - 1279. [Full Text] [PDF]
|
|
|
|
|
|
S. Kasaoka, J. M. Tobis, T. Akiyama, B. Reimers, C. Di Mario, N. D. Wong, and A. Colombo Angiographic and intravascular ultrasound predictors of in-stent restenosis J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1630 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lafont and D. Faxon Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? Cardiovasc Res, July 1, 1998; 39(1): 50 - 59. [Full Text] [PDF]
|
|
|
|
|
|
J. P. O'Malley, J. P. BS, C. L. Maslen, and D. R. Illingworth Angiotensin-Converting Enzyme DD Genotype and Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia Circulation, May 19, 1998; 97(18): 1780 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Challah, E. Villard, M. Philippe, A. Ribadeau-Dumas, B. Giraudeau, P. Janiak, J.-P. Vilaine, F. Soubrier, and J.-B. Michel Angiotensin I-Converting Enzyme Genotype Influences Arterial Response to Injury in Normotensive Rats Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ribichini, G. Steffenino, A. Dellavalle, G. Matullo, E. Colajanni, T. Camilla, A. Vado, G. Benetton, E. Uslenghi, and A. Piazza Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme : A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis Circulation, January 20, 1998; 97(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lindpaintner Genetics of Interventional Cardiology : Old Principles, New Frontiers Circulation, July 1, 1997; 96(1): 12 - 14. [Full Text]
|
|